illumiSonics’ technology a revolutionary step in cancer diagnosisMar 18, 20241 min readUpdated: Sep 2, 2025Featured in David Johnston Research + Technology Park newsletter. Read more here.
illumiSonics Announces Publication in Diagnostics Showing Strong Diagnostic Concordance Between PARS® Label-Free Virtual H&E and Conventional H&E Staining in Skin Cancer
illumiSonics and Sunnybrook Launch INOVAIT-Funded Clinical Trial Evaluating Label-Free Laser Histology in Mohs Surgery
